Skip to main content

The Eshelman Institute for Innovation, Eshelman School of Pharmacy, Lineberger Comprehensive Cancer Center, and UNC School of Medicine have come together to build upon UNC’s world class drug discovery infrastructure, expand its capabilities through external partnerships, and fund promising UNC therapeutic programs. The ultimate goal is to help advance such programs further down the translational path and maximize the chances of reaching patients with novel treatments while realizing value for UNC and its researchers.

 

The Drug Discovery Initiative Joint Steering Committee

The Drug Discovery Initiative is lead by a Joint Steering Committee (JSC) of UNC’s leadership in health sciences. The JSC manages and works to accomplish the mission of the Drug Discovery Initiative by making project funding decisions, infrastructure allocation, management fee determinations, and defining scientific focus.

Bamforth

John Bamforth, PhD

Director, Eshelman Institute for Innovation

Damania

Blossom Damania, PhD

Boshamer Distinguished Professor
Vice Dean for Research, UNC School of Medicine

Earp

Shelley Earp, MD

Distinguished Professor, Lineberger Professor of Cancer Research
Director, UNC Lineberger Comprehensive Cancer Center

 

Stephen Frye, PhD

Fred Eshelman Distinguished Professor
Co-Director, Center for Integrative Chemical Biology and Drug Discovery

Kashuba

Angela Kashuba, BScPhm, PharmD, DABCP, FCP

John A. and Margaret P. McNeill, Sr. Distinguished Professor
Dean, UNC Eshelman School of Pharmacy

Magnuson

Terry Magnuson, PhD

Kay M. & Van L. Weatherspoon Eminent Distinguished Professor of Genetics
UNC Vice Chancellor for Research, University of North Carolina – Chapel Hill